Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy

• Váldodahkkit: O. Honma (Dahkki), C. Watanabe (Dahkki), H. Fukuchimoto (Dahkki), J. Kashiwazaki (Dahkki), M. Tateba (Dahkki), S. Wagatsuma (Dahkki), K. Ogata (Dahkki), K. Maki (Dahkki), H. Sonou (Dahkki), K. Shiga (Dahkki), E. Otsuka (Dahkki), M. Hiruta (Dahkki), Y. Hirasawa (Dahkki), M. Hosonuma (Dahkki), M. Murayama (Dahkki), Y. Narikawa (Dahkki), H. Toyoda (Dahkki), T. Tsurui (Dahkki), A. Kuramasu (Dahkki), M. Kin (Dahkki), Y. Kubota (Dahkki), T. Sambe (Dahkki), A. Horiike (Dahkki), H. Ishida (Dahkki), K. Shimada (Dahkki), M. Umeda (Dahkki), T. Tsunoda (Dahkki), K. Yoshimura (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluation of adverse events. On the day of anticancer drug...